SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 4037.
  • 2
    Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 3447.
  • 3
    Bowyer SL, Blane CE, Sullivan DB, Cassidy JT. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983; 103: 8828.
  • 4
    Engel AG, Hohlfeld R, Banker BQ. Inflammatory myopathies. In: Basic and clinical myology. New York: McGraw-Hill; 1994. p. 133583.
  • 5
    Takken T, Spermon N, Helders PJ, Prakken AB, van der Net J. Aerobic exercise capacity in patients with juvenile dermatomyositis. J Rheumatol 2003; 30: 107580.
  • 6
    Constantin T, Ponyi A, Orban I, Molnar K, Derfalvi B, Dicso F, et al. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary: clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Autoimmunity 2006; 39: 22332.
  • 7
    Jones DA, Round JM. Skeletal muscle in health and disease: a textbook of muscle physiology. Manchester: University Press; 1993.
  • 8
    Pachman LM. Juvenile dermatomyositis: pathophysiology and disease expression. Pediatr Clin North Am 1995; 42: 107198.
  • 9
    Resnick JS, Mammel M, Mundale MO, Kottke FJ. Muscular strength as an index of response to therapy in childhood dermatomyositis. Arch Phys Med Rehabil 1981; 62: 129.
  • 10
    Hicks JE, Drinkard B, Summers RM, Rider LG. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum 2002; 47: 11823.
  • 11
    Newman ED, Kurland RJ. P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis: altered energy utilization during exercise. Arthritis Rheum 1992; 35: 199203.
  • 12
    Niermann KJ, Olsen NJ, Park JH. Magnesium abnormalities of skeletal muscle in dermatomyositis and juvenile dermatomyositis. Arthritis Rheum 2002; 46: 47588.
  • 13
    Park JH, Niermann KJ, Ryder NM, Nelson AE, Das A, Lawton AR, et al. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheum 2000; 43: 235967.
  • 14
    Wiesinger GF, Quittan M, Nuhr M, Volc-Platzer B, Ebenbichler G, Zehetgruber M, et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000; 81: 15.
  • 15
    Hebert CA, Byrnes TJ, Baethge BA, Wolf RE, Kinasewitz GT. Exercise limitation in patients with polymyositis. Chest 1990; 98: 3527.
  • 16
    Takken T, van der Net J, Helders PJ. Anaerobic exercise capacity in patients with juvenile-onset idiopathic inflammatory myopathies. Arthritis Rheum 2005; 53: 1737.
  • 17
    Takken T, van der Net J, Helders PJ. The reliability of an aerobic and an anaerobic exercise tolerance test in patients with juvenile onset dermatomyositis. J Rheumatol 2005; 32: 7349.
  • 18
    Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 1989; 42: 4038.
  • 19
    Beenakker EA, van der Hoeven JH, Fock JM, Maurits NM. Reference values of maximum isometric muscle force obtained in 270 children aged 4-16 years by hand-held dynamometry. Neuromuscul Disord 2001; 11: 4416.
  • 20
    Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al, and The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. Arthritis Rheum 1999; 42: 22139.
  • 21
    Feldman BM, Ayling-Campos A, Luy L, Stevens D, Silverman ED, Laxer RM. Measuring disability in juvenile dermatomyositis: validity of the childhood health assessment questionnaire. J Rheumatol 1995; 22: 32631.
  • 22
    Wulffraat N, van der Net JJ, Ruperto N, Kamphuis S, Prakken BJ, Ten Cate R, et al, and the Paediatric Rheumatology International Trials Organisation. The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001; 19(4 Suppl 23 ): S1115.
  • 23
    Huber AM, Hicks JE, Lachenbruch PA, Perez MD, Zemel LS, Rennebohm RM, et al, and the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. J Rheumatol 2001; 28: 110611.
  • 24
    Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, et al, for the Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004; 50: 1595603.
  • 25
    Godfrey S. Exercise testing in children. London: WB Saunders; 1974.
  • 26
    Kuipers H, Verstappen FT, Keizer HA, Geurten P, van Kranenburg G. Variability of aerobic performance in the laboratory and its physiologic correlates. Int J Sports Med 1985; 6: 197201.
  • 27
    Hansen JE, Sue DY, Oren A, Wasserman K. Relation of oxygen uptake to work rate in normal men and men with circulatory disorders. Am J Cardiol 1987; 59: 66974.
  • 28
    Caiozzo VJ, Davis JA, Ellis JF, Azus JL, Vandagriff R, Prietto CA, et al. A comparison of gas exchange indices used to detect the anaerobic threshold. J Appl Physiol 1982; 53: 11849.
  • 29
    Whipp BJ, Davis JA, Torres F, Wasserman K. A test to determine parameters of aerobic function during exercise. J Appl Physiol 1981; 50: 21721.
  • 30
    Van Leeuwen PB, van der Net J, Helders PJ, Takken T. Exercise parameters in healthy Dutch children. Geneeskunde en Sport 2004; 37: 12632. In Dutch.
  • 31
    Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990; 28: 63242.
  • 32
    Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale (NJ): Lawrence Erlbaum; 1988.
  • 33
    Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991; 12: 142S58S.
  • 34
    Jerusalem F, Rakusa M, Engel AG, MacDonald RD. Morphometric analysis of skeletal muscle capillary ultrastructure in inflammatory myopathies. J Neurol Sci 1974; 23: 391402.
  • 35
    Takken T, Elst E, van der Net J. Pathophysiological factors which determine the exercise intolerance in patients with juvenile dermatomyositis. Curr Rheumatol Rev 2005; 1: 919.
  • 36
    Nagaraju K, Rider LG, Fan C, Chen YW, Mitsak M, Rawat R, et al. Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis 2006; 3: 2.
  • 37
    Cooper DM, Weiler-Ravell D, Whipp BJ, Wasserman K. Aerobic parameters of exercise as a function of body size during growth in children. J Appl Physiol 1984; 56: 62834.
  • 38
    Drinkard BE, Hicks J, Danoff J, Rider LG. Fitness as a determinant of the oxygen uptake/work rate slope in healthy children and children with inflammatory myopathy. Can J Appl Physiol 2003; 28: 88897.
  • 39
    Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ. Principles of exercise testing and interpretation. 3rd ed. Baltimore (MD): Lippincott, Williams & Wilkins; 1999.
  • 40
    Park JH, Vital TL, Ryder NM, Hernanz-Schulman M, Partain CL, Price RR, et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994; 37: 73646.
  • 41
    Wiesinger GF, Quittan M, Graninger M, Seeber A, Ebenbichler G, Sturm B, et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 1998; 37: 133842.
  • 42
    Pfleiderer B, Lange J, Loske K, Sunderkotter C. Metabolic disturbances during short exercises in dermatomyositis revealed by real-time functional 31P magnetic resonance spectrometry. Rheumatology (Oxford) 2004; 43: 696703.
  • 43
    Cea G, Bendahan D, Manners D, Hilton-Jones D, Lodi R, Styles P, et al. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study. Brain 2002; 125: 163545.
  • 44
    Takken T, Elst E, Spermon N, Helders PJ, Prakken AB, van der Net J. The physiological and physical determinants of functional ability measures in children with juvenile dermatomyositis. Rheumatology (Oxford) 2003; 42: 5915.